These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3973987)

  • 21. Renal allograft survival in patients with positive B cell crossmatch to their donor.
    Morrow CE; Sutherland DE; Fryd DS; Noreen H; Segall M; Bach FH; Najarian JS
    Ann Surg; 1984 Jan; 199(1):75-8. PubMed ID: 6362583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.
    Chavers BM; Sullivan EK; Tejani A; Harmon WE
    Pediatr Transplant; 1997 Aug; 1(1):22-8. PubMed ID: 10084783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of donor-specific transfusions on renal transplantation in children.
    Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O
    Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
    Flechner SM; Kerman RH; Van Buren C; Kahan BD
    Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of histocompatibility tests].
    Nishigaki F; Nozaki M; Nakamura A; Taniguchi M; Kobayashi K; Hirano T
    Rinsho Byori; 1990 Feb; 38(2):151-6. PubMed ID: 2139476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive autologous crossmatches and a successful transplant with an HLA-identical, but not with an HLA-nonidentical, kidney.
    Radvany RM; Soper WD; Andersen RL; Wolf JS
    Transplantation; 1983 Dec; 36(6):654-8. PubMed ID: 6229072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transfusion effect.
    Cecka JM
    Clin Transpl; 1987; ():287-301. PubMed ID: 3154420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UNOS Registry data: effect of transfusions.
    Cicciarelli J
    Clin Transpl; 1990; ():407-16. PubMed ID: 2103162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of blood transfusions on survival of cadaver and living related renal transplants.
    Oei LS; Thompson JS; Corry RJ
    Transplantation; 1979 Dec; 28(6):482-4. PubMed ID: 390787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol.
    Burlingham WJ; Stratta RJ; Mason B; Ambrust MJ; Kalayoglu M; Belzer FO; Sollinger HW
    Transplantation; 1988 Feb; 45(2):342-5. PubMed ID: 3257833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of kidney-graft survival with increased numbers of blood transfusions.
    Opelz G; Terasaki PI
    N Engl J Med; 1978 Oct; 299(15):799-803. PubMed ID: 357971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft survival with high levels of cytotoxic antibodies.
    Feduska NJ; Amend WJ; Vincenti F; Perkins HA; Opelz G; Terasaki PI; Iwaki Y; Duca R; Dodge D; Salvatierra O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.